{"id":"W3181256475","doi":"10.1136/jitc-2021-002552","title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer","year":2021,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Society for Immunotherapy of Cancer; Bladder Cancer Advocacy Network","keywords":"Medicine; Immunotherapy; Urothelial cancer; Guideline; Bladder cancer; Cancer; Atezolizumab; Intensive care medicine; Oncology; Cancer immunotherapy; Internal medicine; Pembrolizumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001096546,0.0005700837,0.001725101,0.0001058879,0.0003727555,0.0000410687,0.0003809312,0.0003189233,0.0008814077],"category_scores_gemma":[0.0001185996,0.0003697193,0.003478543,0.0002975494,0.000321862,0.0001750468,0.00001266157,0.0002946747,5.524415e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000700441,"about_ca_system_score_gemma":0.002982205,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00172892,"about_ca_topic_score_gemma":0.0002343612,"domain_scores_codex":[0.9955955,0.0001235743,0.002427034,0.0005221071,0.0007248884,0.0006069373],"domain_scores_gemma":[0.992161,0.001803758,0.002103298,0.0007987093,0.003009441,0.0001237903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.07410526,0.004350498,0.002630909,0.0002865706,0.02489498,0.000002970866,0.00283195,0.0005466116,0.1367497,0.000187045,0.02022802,0.7331855],"study_design_scores_gemma":[0.04315078,0.009829274,0.002040284,0.0004977412,0.001685318,0.00002335585,0.0005915978,0.0002872802,0.160227,0.0003200457,0.7810333,0.0003139968],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1565982,0.748272,0.02632647,0.03936037,0.0111793,0.01159782,0.006305417,0.00006325889,0.0002971944],"genre_scores_gemma":[0.03081768,0.9018594,0.03483712,0.01343168,0.005702238,0.004908039,0.00008458518,0.0004595788,0.007899692],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7608052,"threshold_uncertainty_score":0.9998755,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06021223239992654,"score_gpt":0.4578172749400112,"score_spread":0.3976050425400847,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}